| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
135,340,000 |
| Market
Cap: |
650.99(M) |
| Last
Volume: |
11,363,101 |
Avg
Vol: |
11,331,682 |
| 52
Week Range: |
$1.94 - $5.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Co.'s primary program, molgramostim nebulizer solution is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor and is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. Molgramostim nebulizer solution is administered once daily by inhalation via a nebulizer, the eFlow® Nebulizer System. The eFlow® Nebulizer System is a reusable electronic inhalation system. Molgramostim was also being investigated in cystic fibrosis (CF) and non-CF patients for the treatment of nontuberculous mycobacterial lung infection, a lung disorder.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
3,439,830 |
4,023,225 |
| Total Buy Value |
$0 |
$0 |
$10,277,564 |
$11,106,809 |
| Total People Bought |
0 |
0 |
12 |
12 |
| Total Buy Transactions |
0 |
0 |
14 |
42 |
| Total Shares Sold |
0 |
187,843 |
187,843 |
187,843 |
| Total Sell Value |
$0 |
$885,322 |
$885,322 |
$885,322 |
| Total People Sold |
0 |
3 |
3 |
3 |
| Total Sell Transactions |
0 |
3 |
3 |
3 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Johnson M Ross |
Director |
– • – |
2006-12-21 |
4 |
D |
$2.57 |
$246,239 |
D/D |
(95,813) |
1,621,779 |
|
- |
|
| Johnson M Ross |
Director |
– • – |
2006-12-21 |
4 |
OE |
$0.49 |
$246,239 |
D/D |
502,528 |
1,717,592 |
|
- |
|
| Levine Evan |
CEO & President |
• • – |
2006-11-13 |
4 |
B |
$2.63 |
$2,630 |
D/D |
1,000 |
4,384,000 |
2.73 |
- |
|
| Goldberg Michael M |
Director |
– • – |
2006-10-15 |
4 |
OE |
$1.25 |
$7,500 |
D/D |
6,000 |
26,000 |
|
- |
|
| Merritt James A |
President & Chf Med OfficerOff |
• – – |
2006-09-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| Levine Evan |
CEO & President |
• • – |
2006-07-24 |
4 |
S |
$2.82 |
$2,820 |
D/D |
(1,000) |
4,383,000 |
|
- |
|
| Levine Evan |
President & CEO |
• • – |
2006-06-28 |
4 |
OE |
$0.50 |
$12,500 |
I/I |
25,000 |
4,320,000 |
|
- |
|
| Levine Evan |
President & CEO |
• • – |
2006-06-26 |
4 |
OE |
$0.50 |
$12,500 |
I/I |
25,000 |
4,295,000 |
|
- |
|
| Levine Evan |
President & CEO |
• • – |
2006-06-23 |
4 |
OE |
$0.50 |
$12,500 |
I/I |
25,000 |
4,270,000 |
|
- |
|
| Levine Evan |
President & CEO |
• • – |
2006-06-21 |
4 |
OE |
$0.50 |
$12,500 |
I/I |
25,000 |
4,245,000 |
|
- |
|
| Levine Evan |
CEO & President |
• • – |
2006-06-19 |
4 |
B |
$3.15 |
$3,150 |
D/D |
1,000 |
4,384,000 |
2.73 |
- |
|
| Levine Evan |
CEO & President |
• • – |
2006-05-18 |
4 |
B |
$4.36 |
$4,360 |
D/D |
1,000 |
4,383,000 |
2.73 |
- |
|
| Levine Evan |
CEO & President |
• • – |
2006-05-05 |
4 |
B |
$4.47 |
$4,470 |
D/D |
1,000 |
4,382,000 |
2.73 |
- |
|
| Levine Evan |
CEO & President |
• • – |
2006-05-01 |
4 |
B |
$5.15 |
$5,150 |
D/D |
1,000 |
4,381,000 |
2.81 |
- |
|
| Levine Evan |
President & CEO |
• • – |
2006-04-24 |
4 |
OE |
$0.50 |
$12,801 |
I/I |
25,601 |
4,220,000 |
|
- |
|
| Levine Evan |
CEO & President |
• • – |
2006-02-23 |
4 |
S |
$4.29 |
$8,580 |
D/D |
(2,000) |
4,380,000 |
|
- |
|
| Levine Evan |
CEO & President |
• • – |
2006-01-06 |
4 |
B |
$3.86 |
$7,730 |
D/D |
2,000 |
4,382,000 |
2.81 |
- |
|
| Levine Evan |
CEO & President |
• • – |
2006-01-03 |
4 |
S |
$3.22 |
$3,864 |
D/D |
(1,200) |
4,380,000 |
|
- |
|
| Levine Evan |
CEO & President |
• • – |
2005-10-27 |
4 |
S |
$3.16 |
$12,008 |
D/D |
(3,800) |
4,381,200 |
|
- |
|
| Levine Evan |
President and CEO |
• • – |
2005-09-14 |
4 |
OE |
$0.50 |
$27,200 |
I/I |
54,399 |
4,194,399 |
|
- |
|
| Levine Evan |
President and CEO |
• • – |
2005-09-13 |
4 |
AS |
$3.50 |
$98,350 |
I/I |
(28,100) |
4,140,000 |
|
- |
|
| Levine Evan |
President and CEO |
• • – |
2005-09-12 |
4 |
AS |
$3.60 |
$94,819 |
I/I |
(26,299) |
4,168,100 |
|
- |
|
| Cci Offshore Corp. |
10% Owner |
– – • |
2005-07-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,324,324 |
|
- |
|
| Carlander Carrie |
CFO, Treasurer, VP Finance |
• – – |
2005-06-15 |
4 |
AB |
$2.90 |
$14,500 |
D/D |
5,000 |
25,000 |
|
- |
|
| Carlander Carrie |
CFO, Treasurer, VP Finance |
• – – |
2005-05-31 |
4 |
AB |
$2.25 |
$11,250 |
D/D |
5,000 |
20,000 |
|
- |
|
239 Records found
|
|
Page 9 of 10 |
|
|
0.22 (4.79%) 
